Evidence map›Paper›PMID 39927767›Full record

ArticleAntimicrobial agents and chemotherapy2025

Isolation and characterization of

Daniel Kiboi, Juliana M Sá, Akshaykumar Nayak, Chiara E Micchelli, Shuchi N Amin, Alexander G Burbelo, Sasha A Abielmona, Brian Xi, Lucia A Mulei, Noah M Onchieku and 3 more

Abstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Identification of an Orally Efficacious Imidazo[4,5-Journal of medicinal chemistry · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Daniel KiboiLaboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland, USA.ORCID 0000-0003-0797-7378
Juliana M SáLaboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland, USA.
Akshaykumar NayakLaboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland, USA.
Chiara E MicchelliLaboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland, USA.
Shuchi N AminLaboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland, USA.
Alexander G BurbeloLaboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland, USA.
Sasha A AbielmonaLaboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland, USA.
Brian XiLaboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland, USA.
Lucia A MuleiLaboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland, USA.
Noah M OnchiekuLaboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland, USA.ORCID 0000-0003-2462-139X
Caroline M PercopoLaboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland, USA.
Jianbing MuLaboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland, USA.ORCID 0000-0001-6012-8389
Thomas E WellemsLaboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland, USA.ORCID 0000-0003-3899-8454

Funding

PLASMODIUM CHROMOSOME ORGANIZATION &GENOMIC RESTRUCTURING IN RESPONSE TO STRESSZ01AI000483 · NIAID · NIAID EXTRAMURAL ACTIVITIES · PI WELLEMS, THOMAS E · 1986 to 2008
$1.5M
HHS | NIH | NIAID | Division of Intramural Research (DIR, NIAID) AI000483Intramural NIH HHS Z01 AI000483
6 · The paper itself

Abstract

Artemisinin-based combination therapies (ACTs) are vital for malaria treatment, but these are threatened by blood-stage persisters-dormant forms of

Indexed as

AntimalarialsArtemisininsPlasmodium falciparumErythrocytesHumansMalaria, FalciparumAntimalarialsArtemisininsartenimolartemisininautophagydormancydrug resistancemalariarecrudescence

Identifiers

PMID39927767
PMCPMC11881564

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.